Inger Björck Selected Research

Inger Björck Research Topics

5	Type 2 Diabetes Mellitus (MODY) 10/2021 - 02/2003
4	Inflammation (Inflammations) 10/2021 - 01/2013
4	Overweight 01/2020 - 08/2004
4	Body Weight (Weight, Body) 10/2016 - 08/2004
3	Insulin Resistance 06/2016 - 08/2004
2	Obesity 10/2021 - 01/2013
2	Cognitive Dysfunction 01/2013 - 11/2012
1	Weight Loss (Weight Reduction) 01/2023
1	Infections 10/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2004
1	Ulcerative Colitis 03/2003

6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2013
6	Insulin (Novolin)FDA Link 10/2016 - 02/2003
4	CarbohydratesIBA 06/2019 - 08/2004
3	Blood Glucose (Blood Sugar)IBA 10/2021 - 01/2016
2	LipidsIBA 01/2023 - 10/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2016 - 01/2013
2	Hormones (Hormone)IBA 10/2016 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 02/2010 - 08/2004
1	lipopolysaccharide-binding proteinIBA 10/2021
1	Amino Acids FDA Link 01/2020
1	ChromiumIBA 01/2020
1	PolyphenolsIBA 01/2017
1	HydrogenIBA 10/2016
1	Plasminogen Activator Inhibitor 1IBA 10/2016
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2012
1	LeptinIBA 02/2010
1	CholesterolIBA 02/2010
1	HDL CholesterolIBA 08/2004
1	Nonesterified Fatty Acids (NEFA)IBA 08/2004
1	LDL CholesterolIBA 08/2004
1	Butyrates (Butyrate)IBA 03/2003

1	Diet Therapy (Therapy, Diet) 02/2003